{"id":"https://openalex.org/W7224905167","doi":"https://doi.org/10.5281/zenodo.23795707","title":"A STUDY ON DRUG UTILIZATION PATTERNS IN RESPIRATORY TRACT INFECTIONS AT A SECONDARY CARE HOSPITAL","display_name":"A STUDY ON DRUG UTILIZATION PATTERNS IN RESPIRATORY TRACT INFECTIONS AT A SECONDARY CARE HOSPITAL","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224905167","doi":"https://doi.org/10.5281/zenodo.23795707"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23795707","doi":"https://doi.org/10.5281/zenodo.23795707","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23795707","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23795707","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160218194","display_name":"Dr. Nagarjuna D.*1, Dr. R. S. Meghasri*2, Dr. Shivaraj Dr.*3, Shrinivas Patil4, Kavyashree D.5, Manu S. T.6","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dr. Nagarjuna D.*1, Dr. R. S. Meghasri*2, Dr. Shivaraj Dr.*3, Shrinivas Patil4, Kavyashree D.5, Manu S. T.6","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160218194"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.89034469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.8744999766349792,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.8744999766349792,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.07280000299215317,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.036400001496076584,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.777999997138977},{"id":"https://openalex.org/keywords/respiratory-tract-infections","display_name":"respiratory infections","score":0.996999979019165},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.9559999704360962},{"id":"https://openalex.org/keywords/rational-drug-use","display_name":"rational drug use","score":0.9139999747276306},{"id":"https://openalex.org/keywords/antimicrobial-use","display_name":"antimicrobial use","score":0.8669999837875366},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/pneumonia","display_name":"pneumonia","score":0.843999981880188},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.8880000114440918},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.9309999942779541},{"id":"https://openalex.org/keywords/secondary-care-hospital","display_name":"secondary care hospital","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.916100025177002},{"id":"https://openalex.org/C2776012195","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory tract infections","level":3,"score":0.6567999720573425},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6197999715805054},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5925999879837036},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5483999848365784},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5426999926567078},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.5411999821662903},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5235999822616577},{"id":"https://openalex.org/C3017744659","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Secondary care","level":3,"score":0.4860999882221222},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.4595000147819519},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.41269999742507935},{"id":"https://openalex.org/C2910723583","wikidata":"https://www.wikidata.org/wiki/Q65066344","display_name":"Drug Utilization Review","level":3,"score":0.40290001034736633},{"id":"https://openalex.org/C2776710477","wikidata":"https://www.wikidata.org/wiki/Q1957663","display_name":"Hospital-acquired pneumonia","level":3,"score":0.38760000467300415},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3695000112056732},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3540000021457672},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.3483000099658966},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.3285999894142151},{"id":"https://openalex.org/C2776102371","wikidata":"https://www.wikidata.org/wiki/Q460030","display_name":"Community-acquired pneumonia","level":3,"score":0.322299987077713},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.31610000133514404},{"id":"https://openalex.org/C2776399701","wikidata":"https://www.wikidata.org/wiki/Q3631290","display_name":"Lower respiratory tract infection","level":4,"score":0.311599999666214},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3109999895095825},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.30550000071525574},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.3027999997138977},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.29899999499320984},{"id":"https://openalex.org/C129930760","wikidata":"https://www.wikidata.org/wiki/Q1702613","display_name":"Pharmaceutical care","level":3,"score":0.28870001435279846},{"id":"https://openalex.org/C2909960733","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial drug","level":3,"score":0.2883000075817108},{"id":"https://openalex.org/C10446079","wikidata":"https://www.wikidata.org/wiki/Q155491","display_name":"Clinical pharmacy","level":3,"score":0.2856000065803528},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28290000557899475},{"id":"https://openalex.org/C2993183539","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory infection","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C3017566137","wikidata":"https://www.wikidata.org/wiki/Q5308929","display_name":"Drug usage","level":3,"score":0.25780001282691956},{"id":"https://openalex.org/C2776345407","wikidata":"https://www.wikidata.org/wiki/Q3776920","display_name":"Bacterial pneumonia","level":3,"score":0.2508000135421753}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23795707","doi":"https://doi.org/10.5281/zenodo.23795707","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23795707","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23795708","doi":"https://doi.org/10.5281/zenodo.23795708","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23795708","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23795707","doi":"https://doi.org/10.5281/zenodo.23795707","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23795707","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3175626154","https://openalex.org/W4405703349","https://openalex.org/W2762195514","https://openalex.org/W4312749428","https://openalex.org/W2618324776","https://openalex.org/W6892806269","https://openalex.org/W7131349702","https://openalex.org/W7220435125","https://openalex.org/W2944973747","https://openalex.org/W2978400855"],"abstract_inverted_index":{"Respiratory":[0,53],"tract":[1,54],"Infections":[2,55],"(RTI's)":[3],"are":[4,165,195],"among":[5,49,77],"the":[6,34,45,63,91,98,134],"most":[7,159,173],"common":[8],"Infectious":[9],"conditions":[10],"encountered":[11],"in":[12,39,133,253],"clinical":[13,40,176],"practice":[14],"and":[15,22,33,61,65,82,101,121,142,147,168,172,183,223,243,262,267,272,278],"contribute":[16],"substantially":[17],"to":[18,153,241,257],"morbidity,":[19],"healthcare":[20],"utilisation":[21,47,105],"antimicrobial":[23,118],"consumption.":[24],"Drug-utilisation":[25],"studies":[26,237],"provide":[27,239],"important":[28],"information":[29],"regarding":[30],"prescribing":[31,112,123,246],"patterns":[32],"rational":[35],"use":[36,264],"of":[37,67,128,136,198,228,247,255,265],"medicines":[38],"settings.":[41],"Objective:":[42],"To":[43],"evaluate":[44],"drug":[46,217],"pattern":[48],"patients":[50,78,89,130,151],"diagnosed":[51,79],"with":[52,80,108],"at":[56,84],"a":[57,85,259],"secondary":[58,86],"Care":[59,87],"hospital":[60],"assess":[62],"rationality":[64],"appropriateness":[66],"prescribed":[68,202,210,216,230],"medications.":[69],"Methodology:":[70],"A":[71,126],"Prospective":[72],"observational":[73],"study":[74,99],"was":[75,106,163],"conducted":[76],"RTI's":[81],"treated":[83],"hospital.":[88],"fulfilling":[90],"predefined":[92],"Inclusion":[93],"criteria":[94],"were":[95,131,140,145,155,178,188,201,208],"enrolled":[96],"during":[97],"period":[100],"followed":[102,212],"prospectively":[103],"Drug":[104,235],"assessed":[107],"particular":[109],"emphasis":[110],"on":[111],"Patterns,":[113],"commonly":[114,174,215],"used":[115],"Therapeutic":[116],"classes,":[117],"use,":[119],"polypharmacy,":[120],"relevant":[122],"Indicators.":[124],"Results:":[125],"total":[127],"106":[129],"Included":[132,219],"study,":[135],"whom":[137],"75":[138],"(70.75%)":[139],"male":[141],"31":[143],"(29.24%)":[144],"females,":[146],"highest":[148],"age":[149],"group":[150],"belongs":[152],"51-60":[154],"33":[156],"(31.13%).":[157],"The":[158,226],"frequently":[160,184,209],"observed":[161,185],"RTI":[162,256],"Pneumonia":[164],"25":[166],"(23.58%)":[167],"COPD":[169],"24":[170],"(22.64%)":[171],"Reported":[175],"manifestation":[177],"cough":[179],"as":[180],"81":[181],"(21.48%)":[182],"co-morbid":[186],"condition":[187],"HTN's":[189],"21":[190],"(36.84%).":[191],"Total":[192],"632":[193],"medications":[194,229],"prescribed.":[196],"out":[197],"those":[199],"Antibiotics":[200],"high":[203],"136":[204],"(21.51%),":[205],"cephalosporins":[206],"class":[207],"(i.e.,ceftriaxone)":[211],"by":[213,231],"other":[214,224],"classes":[218],"Bronchodilators,":[220],"corticosteroids,":[221],"mucolytics":[222],"classes.":[225],"majority":[227],"Brand":[232],"name.":[233],"Conclusion:":[234],"utilization":[236],"can":[238],"feedback":[240],"physicians":[242],"promote":[244],"Rational":[245],"drugs":[248,266],"enabling":[249],"better":[250,260],"patient":[251],"care":[252],"management":[254],"choose":[258],"effectiveness":[261],"safe":[263],"educated":[268],"for":[269],"more":[270],"appropriate":[271],"cost-effective":[273],"prescribing,":[274],"thereby":[275],"minimizing":[276],"Polypharmacy":[277],"Antimicrobial":[279],"resistance.":[280]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}